Shorts

How Breast Cancer Cells "Hide" From Treatment: Ateequllah Hayat, PhD

Why 100% Skin Clearance Is Not Always Enough: James Song, MD

PBM Reform Hinges on Making Prices Transparent for All: Miriam Paramore

Advanced Multiple Myeloma Therapies Require Dedicated Teams, 24/7 Support for Safe Patient Care: Ameet Patel, MD

Access, Geography, and Cost Limit Patient Participation in Clinical Trials: Susan Vadaparampil, PhD, MPH

How Successful Medically Integrated Dispensing Works in Practice: Kenneth Komorny, PharmD, BCPS

Weighing the Pros, Cons of Medically Integrated Dispensing: Katherine Tobon, PharmD, BCOP

Strengthening Trial Infrastructure to Broaden Patient Access: Tina Bhatnagar, DO

Restoring the Optic Nerve a Primary Goal in the Future of Glaucoma Treatment: Ariana Levin, MD

Glaucoma Seeing Emerging Therapies in Eye Drops, Surgery Modalities: Jullia Rosdahl, MD, PhD

Catching Glaucoma Early Relies on Consistent Testing With Eye Doctors: Ariana Levin, MD

Closing Data Gaps in Precision Oncology: Tina Bhatnagar, DO

Glaucoma Can Be Mitigated Through Screening Those at Highest Risk: Manjool Shah, MD

Increased Influenza Hospitalizations Underscore the Need for Stronger Prevention Strategies: Marco del Riccio, MD

Laser, Eye Drops Are First-Line Treatment for Glaucoma: Jullia Rosdahl, MD, PhD

Integrated, Age-Specific Care Is Essential for Young Patients With Breast Cancer: Yara Abdou, MD

Glaucoma Known as the "Silent Thief" of Vision: Manjool Shah, MD

Patient–Investigator Collaboration Drives Health Care Innovation: Debra Patt, MD, PhD, MBA, MPH

Transforming Survivor Care in Emergency Departments: Prashasti Bhatnagar, Esq, MPH

Subsidy Expiration Could Reshape ICHRA Access: Matthew McGough, MSPH

Will Your Health Insurance Premiums Double? Matthew McGough, MSPH

SDOH Could Reshape HCM Risk Guidelines and Care Pathways: Neha Hafeez, MD

Why Social Context Matters in Heart Disease Care: Neha Hafeez, MD

Why Fractionated Radiotherapeutic Dosing May Improve Outcomes in LM Treatment: Andrew Brenner, MD

How Rhenium Nanoliposomes Target Leptomeningeal Metastases: Andrew Brenner, MD

Understanding LM Therapy Across Breast Cancer Subtypes: Andrew Brenner, MD

Changes to USAID Affected Worldwide HIV Response: Antonio Urbina, MD

Getting Lenacapavir on Insurance Plans Is Key to Uptake: Antonio Urbina, MD

DTC Models Offer Promise for Some, but Remain Limited in Scope: Brian Reid, MS

Treatments for Symptom-Driven Conditions Are the Best Fit for DTC Models: Jennifer Graff, PharmD